Franconieri F, Martin-Silva N, de Boysson H, Galateau-Salle F, Emile J-F, Bienvenu B, et al. Superior efficacy and tolerance of reduced doses of vemurafenib plus anakinra in Erdheim-Chester disease: Towards the paradigm of combined targeting and immune therapies. AO [Internet]. 2016 Jul. 2 [cited 2025 Feb. 16];55(7):930-2. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/25500